These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38301904)

  • 1. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
    Al Farii H; McChesney G; Patel SS; Rhines LD; Lewis VO; Bird JE
    Spine J; 2024 Jun; 24(6):1056-1064. PubMed ID: 38301904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
    Yonezawa N; Murakami H; Kato S; Takeuchi A; Tsuchiya H
    Eur Spine J; 2017 May; 26(Suppl 1):236-242. PubMed ID: 28396950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent giant cell tumour of the thoracic spine managed by total en bloc spondylectomy and denosumab therapy: a case report.
    Duan PG; Sheng YH; Deng CH; Tang BY; Yao HQ
    BMC Musculoskelet Disord; 2020 Feb; 21(1):105. PubMed ID: 32061254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases.
    Dubory A; Missenard G; Domont J; Court C
    Spine (Phila Pa 1976); 2016 Jun; 41(11):E654-E660. PubMed ID: 27244112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
    Mattei TA; Ramos E; Rehman AA; Shaw A; Patel SR; Mendel E
    Spine J; 2014 Jul; 14(7):e15-21. PubMed ID: 24534393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
    Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
    Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological Transformation of Giant-Cell Tumor of Bone After Treatment with Denosumab: A Case Report.
    Zhang Y; Ilaslan H; Krishnaney AA; Bauer TW
    JBJS Case Connect; 2016; 6(3):e74. PubMed ID: 29252651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant cell tumors of the spine: has denosumab changed the treatment paradigm?
    Goldschlager T; Dea N; Boyd M; Reynolds J; Patel S; Rhines LD; Mendel E; Pacheco M; Ramos E; Mattei TA; Fisher CG
    J Neurosurg Spine; 2015 May; 22(5):526-33. PubMed ID: 25700239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Denosumab cure giant cell tumors of the spine? A case report and literature review.
    Xará-Leite F; Coutinho L; Fleming C; Magalhães M; Oliveira V; Rodrigues-Pinto R; Cardoso P
    Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):19-23. PubMed ID: 31529151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter to the editor regarding "The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature" by Humaid et al.
    Niu HQ; Zheng BY; Wu HL; Zheng BW
    Spine J; 2024 Jul; 24(7):1335-1337. PubMed ID: 38910017
    [No Abstract]   [Full Text] [Related]  

  • 12. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
    Agarwal MG; Gundavda MK; Gupta R; Reddy R
    Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant cell tumor of the sacrum and spine: series of 23 cases and a review of the literature.
    Martin C; McCarthy EF
    Iowa Orthop J; 2010; 30():69-75. PubMed ID: 21045974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
    Deveci MA; Paydaş S; Gönlüşen G; Özkan C; Biçer ÖS; Tekin M
    Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report.
    Tang Q; Lu J; Zhu X; Song G; Wu H; Xu H; Wang A; Wang J
    Eur Spine J; 2023 Dec; 32(12):4297-4305. PubMed ID: 37318598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
    Zhang RZ; Ma TX; Qi DW; Zhao M; Hu T; Zhang GC
    Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denosumab in the treatment of giant cell tumor of the spine. Preliminary report, review of the literature and protocol proposal.
    Boriani S; Cecchinato R; Cuzzocrea F; Bandiera S; Gambarotti M; Gasbarrini A
    Eur Spine J; 2020 Feb; 29(2):257-271. PubMed ID: 31098716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic Changes After Denosumab Therapy in Patients with Giant Cell Tumor of the Spine: Report of Four Cases and a Review of the Literature.
    Yonezawa N; Murakami H; Demura S; Kato S; Yoshioka K; Takeuchi A; Shinmura K; Yokogawa N; Shimizu T; Oku N; Kitagawa R; Handa M; Tsuchiya H
    World Neurosurg; 2019 Jul; 127():38-46. PubMed ID: 30926552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
    Hindiskere S; Errani C; Doddarangappa S; Ramaswamy V; Rai M; Chinder PS
    Clin Orthop Relat Res; 2020 Nov; 478(11):2522-2533. PubMed ID: 32401001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denosumab salvage therapy in an 11-year-old boy with locally recurrent unresectable giant cell tumor of the lumbar spine after surgery.
    Luo Y; Xiu P; Chen H; Zeng J; Song Y; Li T
    Neurochirurgie; 2023 May; 69(3):101427. PubMed ID: 36828057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.